260 related articles for article (PubMed ID: 12406558)
1. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells.
Chen Z; Clark S; Birkeland M; Sung CM; Lago A; Liu R; Kirkpatrick R; Johanson K; Winkler JD; Hu E
Cancer Lett; 2002 Dec; 188(1-2):127-40. PubMed ID: 12406558
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
Chen YX; Fang JY; Lu J; Qiu DK
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity.
Blagosklonny MV; Robey R; Sackett DL; Du L; Traganos F; Darzynkiewicz Z; Fojo T; Bates SE
Mol Cancer Ther; 2002 Sep; 1(11):937-41. PubMed ID: 12481415
[TBL] [Abstract][Full Text] [Related]
5. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.
Herold C; Ganslmayer M; Ocker M; Hermann M; Geerts A; Hahn EG; Schuppan D
J Hepatol; 2002 Feb; 36(2):233-40. PubMed ID: 11830335
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
7. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells.
Kim YB; Ki SW; Yoshida M; Horinouchi S
J Antibiot (Tokyo); 2000 Oct; 53(10):1191-200. PubMed ID: 11132966
[TBL] [Abstract][Full Text] [Related]
9. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
[TBL] [Abstract][Full Text] [Related]
11. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
12. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad.
Sawa H; Murakami H; Ohshima Y; Sugino T; Nakajyo T; Kisanuki T; Tamura Y; Satone A; Ide W; Hashimoto I; Kamada H
Brain Tumor Pathol; 2001; 18(2):109-14. PubMed ID: 11908866
[TBL] [Abstract][Full Text] [Related]
14. p15(INK4b) in HDAC inhibitor-induced growth arrest.
Hitomi T; Matsuzaki Y; Yokota T; Takaoka Y; Sakai T
FEBS Lett; 2003 Nov; 554(3):347-50. PubMed ID: 14623092
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
16. Effect of Zebularine in Comparison to and in Combination with Trichostatin A on CIP/KIP Family (p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2), DNMTs (DNMT1, DNMT3a, and DNMT3b), Class I HDACs (HDACs 1, 2, 3) and Class II HDACs (HDACs 4, 5, 6) Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer LS 174T Cell Line.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2131-2139. PubMed ID: 32711442
[TBL] [Abstract][Full Text] [Related]
17. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.
Archer SY; Meng S; Shei A; Hodin RA
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6791-6. PubMed ID: 9618491
[TBL] [Abstract][Full Text] [Related]
18. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.
Kamitani H; Taniura S; Watanabe K; Sakamoto M; Watanabe T; Eling T
Neuro Oncol; 2002 Apr; 4(2):95-101. PubMed ID: 11916500
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo.
Leng SL; Leeding KS; Gibson PR; Bach LA
Carcinogenesis; 2001 Oct; 22(10):1625-31. PubMed ID: 11577001
[TBL] [Abstract][Full Text] [Related]
20. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
